Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05475457 · ClinicalTrials.gov registry record
Oregon Supplement: Supporting Sustainable Positive Interactions in the Child Welfare System: The R3 Supervisor Strategy
A clinical trial, sponsored by Oregon Social Learning Center.
- Completed
- Registry status
- 404
- Enrollment target
NCT05475457: Completed study, sponsored by Oregon Social Learning Center.
NCT05475457 is a clinical trial that has completed, run by Oregon Social Learning Center. The registered enrollment target is 404 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05475457 has completed, sponsored by Oregon Social Learning Center.
- COMPLETED
- Registry status
- 404 participants
- Enrollment target
Study Summary
This administrative supplement capitalized on the preliminary positive outcomes from the primary parent grant award (R01DA040416), and lessons learned from the implementation of the R3 Supervisor Strategy (R3) throughout the participating four regions (12 counties) in Tennessee. This project aimed to pilot the implementation of R3 with a new sample, a cohort of counties in Oregon particularly affected by the current opioid epidemic, for potential scale-up.
Primary Outcome
Changes in overall organizational support of evidence-based practices (i.e., R3) as measured through the Implementation Citizenship Behavior Scale's (ICBS) total score. Measured at Baseline, 6-, 12-, and 18-months Post-Baseline.
Interventions
- BEHAVIORAL R3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 404 participants |
| Start Date | 2019-04-08 |
| Est. Completion | 2021-07-16 |
What the finished NCT05475457 record still lists
NCT05475457 is an observational study that tracks outcomes without assigning an intervention. The registered 404 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which R3 is the first listed.
NCT05475457 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05475457 about?
NCT05475457 is a clinical study titled "Oregon Supplement: Supporting Sustainable Positive Interactions in the Child Welfare System: The R3 Supervisor Strategy". This administrative supplement capitalized on the preliminary positive outcomes from the primary parent grant award (R01DA040416), and lessons learned from the implementation of the R3 Supervisor Strategy (R3) throughout the participating four regions (12 counties) in Tennessee. This project aimed t...
What is the current status of trial NCT05475457?
This trial is currently completed. The enrollment target is 404 participants. The study started on 2019-04-08. Estimated completion is 2021-07-16.
What interventions are being tested in trial NCT05475457?
The interventions under investigation include: R3 (BEHAVIORAL).
Who is sponsoring clinical trial NCT05475457?
This trial is sponsored by Oregon Social Learning Center, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05049057 · 404 participants · Phase 2
Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI
- NCT05611242 · 404 participants · Phase 3
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
- NCT06072612 · 404 participants · Phase 3
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- NCT05576350 · 405 participants · NA
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI